Stay updated with breaking news from 09057220. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target […]
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) will announce its earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $2.04 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. Bio-Rad Laboratories (NYSE:BIO – Get Free […]
IFM Investors Pty Ltd bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,057 shares of the medical research company’s stock, valued at approximately $1,403,000. Other hedge funds and other […]
StockNews.com upgraded shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a hold rating to a buy rating in a report published on Thursday morning. Several other research firms also recently issued reports on BIO. Citigroup downgraded shares of Bio-Rad Laboratories from a buy rating to a neutral rating and dropped their price target for […]